Exercise or conversion
Brian Savage
Interim Chief Legal Officer
Ordinary Shares
- Value context
- $156.25K
- Reported price
- $34.70 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
TEVA PHARMACEUTICAL INDUSTRIES LTD
Last 30 daysNo qualifying insider buying. Sales: $14.64M by 2 insiders.
Showing the first 6 of 20 trades on this page.
Interim Chief Legal Officer
Ordinary Shares
Interim Chief Legal Officer
Ordinary Shares
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Interim Chief Legal Officer
Ordinary Shares
Interim Chief Legal Officer
Ordinary Shares
Interim Chief Legal Officer
Stock Options (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Ordinary Shares
Chief Accounting Officer
Ordinary Shares
Chief Accounting Officer
Ordinary Shares
Chief Accounting Officer
Ordinary Shares
Chief Accounting Officer
Stock Options (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Ordinary Shares
EVP, Business Development
Ordinary Shares
Director
Ordinary Shares
See "Remarks"
Ordinary Shares
See "Remarks"
Ordinary Shares
See "Remarks"
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
See "Remarks"
Ordinary Shares
See "Remarks"
Ordinary Shares
See "Remarks"
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, Global Operations
Ordinary Shares
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Interim Chief Legal Officer | Ordinary SharesOption exercise or conversion | 4,503$34.70 / share | $156.25K | Sep 18Filed Sep 22 · 4d later | SEC filing |
| Interim Chief Legal Officer | Ordinary SharesSale3 trades | 7,342avg $38.85 / share | $285.22K | Sep 18Filed Sep 22 · 4d later | 3 filings
|
| Interim Chief Legal Officer | Stock Options (right to buy)Option exercise or conversion | Derivative units4,503$34.70 exercise / conversion price | Not a separate purchase | Sep 18Filed Sep 22 · 4d later | SEC filing |
| Director | Ordinary SharesSale | 367,600$39.06 / share | $14.36M | Sep 18Filed Sep 22 · 4d later | SEC filing |
| Chief Accounting Officer | Ordinary SharesSale | 6,945$37.61 / share | $261.22K | Aug 21Filed Aug 25 · 4d later | SEC filing |
| Chief Accounting Officer | Ordinary SharesOption exercise or conversion | 2,500$19.61 / share | $49.03K | Aug 21Filed Aug 25 · 4d later | SEC filing |
| Chief Accounting Officer | Ordinary SharesSale | 2,500$37.63 / share | $94.08K | Aug 21Filed Aug 25 · 4d later | SEC filing |
| Chief Accounting Officer | Stock Options (right to buy)Option exercise or conversion | Derivative units2,500$19.16 exercise / conversion price | Not a separate purchase | Aug 21Filed Aug 25 · 4d later | SEC filing |
| Director | Ordinary SharesSale | 415$37.25 / share | $15.46K | Aug 21Filed Aug 25 · 4d later | SEC filing |
| EVP, Business Development | Ordinary SharesSale10b5-1 | 18,600$36.57 / share | $680.29K | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Director | Ordinary SharesSale | 17$34.87 / share | $592.71 | Aug 5Filed Aug 10 · 5d later | SEC filing |
| See "Remarks" | Ordinary SharesOption exercise or conversion10b5-1 | 12,827Price not reported | Unavailable | Aug 3Filed Aug 5 · 2d later | SEC filing |
| See "Remarks" | Ordinary SharesSale10b5-1 | 12,827$34.88 / share | $447.35K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| See "Remarks" | Restricted Share UnitsOption exercise or conversion10b5-1 | Derivative units12,827Exercise / conversion price not reported | Not a separate purchase | Aug 3Filed Aug 5 · 2d later | SEC filing |
| See "Remarks" | Ordinary SharesOption exercise or conversion10b5-1 | 52,744Price not reported | Unavailable | Aug 3Filed Aug 5 · 2d later | SEC filing |
| See "Remarks" | Ordinary SharesSale10b5-1 | 25,578$34.88 / share | $892.05K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| See "Remarks" | Restricted Share UnitsOption exercise or conversion10b5-1 | Derivative units52,744Exercise / conversion price not reported | Not a separate purchase | Aug 3Filed Aug 5 · 2d later | SEC filing |
| EVP, Global Operations | Ordinary SharesSale | 9,989$32.19 / share | $321.55K | Jun 18Filed Jun 22 · 4d later | SEC filing |
Showing the latest 20 of 65 trades. Show all 65 trades
Teva Pharmaceutical Industries Limited American Depositary Shares · Stock
The filing reports a purchase for the member.